✦ LIBER ✦

PMH47 Willingness to Pay for Key Attributes of the new Long Acting Injectable Treatments in Schizophrenia

✍ Scribed by R. Jensen; K.J. Sommer; F. Søltoft; A. Schmidt; A.T. Nielsen; M. Garg; C. Mønsted; M. Bøgelund

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH2 EARLY RESPONSE PREDICTS SUBSEQUENT

✍ Ascher-Svanum, H; Zhao, F; Nyhuis, A; Lawson, AH; Stauffer, VL; Montgomery, W; W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH30 COST-EFFECTIVENESS ANALYSIS IN THE

✍ S Crowley; R Schrover; AM Neville 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PMH12 Risk of Relapse and Hospitalizatio

✍ D. Novick; H. Ascher-Svanum; J. Bertsch; H. Detke; D. Mcdonnell; M. Witte; J. Ha 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PMH34 LONG-TERM TREATMENT OF SCHIZOPHREN

✍ D Naber; A Mehnert; D Rosillon; D Farmer; A Schreiner; A Jacobs 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB